Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis
Journal of Clinical Medicine · 21.03.2024 · 13 (6) · 1818
DOI: 10.3390/jcm13061818 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 21.03.2024. Verfasst von Bálint Bérczi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health Medicine, Medical School, University of Pécs, Szigeti út 12, 7624 Pécs, Hungary. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: “GINOP-2.3.2-15-2016-00048—STAY ALIVE”, Human Resources Development Operational Programme.
Abstract (Originalsprache)
Background
Women are typically diagnosed with estrogen receptor-positive breast cancer around the postmenopausal period when declining estrogen levels initiate changes in lipid profiles. Aromatase inhibitors (AI) are used to prevent the progression of cancer; however, a further reduction in estrogen levels may have detrimental effects on lipid levels, which was our working hypothesis.
Methods
Our meta-analysis was conducted on the lipid profiles of postmenopausal breast cancer patients at baseline and at different treatment time points.
Results
We identified 15 studies, including 1708 patients. Studies using anastrozole (ANA), exemestane (EXE), letrozole (LET), and tamoxifen (TMX) were involved. Subgroup analyses revealed that 3- and 12-month administrations of LET and EXE lead to negative changes in lipid profiles that tend to alter the lipid profile undesirably, unlike ANA and TMX.
Conclusions
Our results suggest that, despite statistically significant results, EXE and LET may not be sufficient to cause severe dyslipidemia in patients without cardiovascular comorbidities according to the AHA/ACC Guideline on the Management of Blood Cholesterol. However, the results may raise the question of monitoring the effects of AIs in patients, especially those with pre-existing cardiovascular risk factors such as dyslipidemia.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Public Health Medicine, Medical School, University of Pécs, Szigeti út 12, 7624 Pécs, Hungary.
- Institute for Translational Medicine, Medical School, University of Pécs, Szigeti út 12, 7624 Pécs, Hungary.
- Institute of Bioanalysis, Medical School, University of Pécs, Szigeti út 12, 7624 Pécs, Hungary.
- First Department of Medicine, University of Szeged, Korányi Fasor 8-10, 6720 Szeged, Hungary.
- Department of Pharmacognosy, University of Szeged, Eötvös u. 6, 6720 Szeged, Hungary.
- Interdisciplinary Centre of Natural Products, University of Szeged, Dugonics tér 13, 6720 Szeged, Hungary.
ORCID-Profile: Bálint Bérczi, Nelli Farkas, Dezső Csupor, Balázs Németh, Anita Lukács, László Márk Czumbel, Andrea Szabó, Gábor Varga, Gábor Gerber, Zoltán Gyöngyi
Förderung
- “GINOP-2.3.2-15-2016-00048—STAY ALIVE”
- Human Resources Development Operational Programme
Zitieren
APA
Bérczi, B., Farkas, N., Hegyi, P., Tóth, B., Csupor, D., Németh, B., Lukács, A., Czumbel, L. M., Kerémi, B., Kiss, I., Szabó, A., Varga, G., Gerber, G., & Gyöngyi, Z. (2024). Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine, 13(6), 1818. https://doi.org/10.3390/jcm13061818
Vancouver
Bérczi B, Farkas N, Hegyi P, Tóth B, Csupor D, Németh B, et al. Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis. Journal of Clinical Medicine. 2024;13(6):1818. doi:10.3390/jcm13061818
BibTeX
@article{Brczi2024,
author = {Bérczi, Bálint and Farkas, Nelli and Hegyi, Péter and Tóth, Barbara and Csupor, Dezső and Németh, Balázs and Lukács, Anita and Czumbel, László Márk and Kerémi, Beáta and Kiss, István and Szabó, Andrea and Varga, Gábor and Gerber, Gábor and Gyöngyi, Zoltán},
title = {Aromatase Inhibitors and Plasma Lipid Changes in Postmenopausal Women with Breast Cancer: A Systematic Review and Meta-Analysis},
journal = {Journal of Clinical Medicine},
year = {2024},
volume = {13},
number = {6},
pages = {1818},
doi = {10.3390/jcm13061818}
}
EUVIMED